Can you provide a concise list of all FDA‑approved medications for bipolar disorder with their dosing specifications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FDA-Approved Bipolar Medications: Comprehensive List with Specifiers

All FDA-approved medications for bipolar disorder are listed below, organized by indication with their specific dosing parameters and approved uses.

Acute Mania/Mixed Episodes

First-Generation Antipsychotics

  • Haloperidol: Effective for acute mania with moderate-to-high certainty evidence 1

Second-Generation Antipsychotics (Monotherapy)

  • Aripiprazole: FDA-approved for acute mania/mixed episodes; also approved for maintenance 2, 1
  • Asenapine: FDA-approved for acute mania/mixed episodes 1, 2
  • Cariprazine: FDA-approved for acute mania/mixed episodes with high certainty evidence 1
  • Olanzapine: FDA-approved for acute mania/mixed episodes; also approved for maintenance 2, 1
  • Quetiapine: FDA-approved for acute mania/mixed episodes (immediate and extended-release formulations) 2, 3
  • Risperidone: FDA-approved for acute mania/mixed episodes 2, 1
  • Ziprasidone: FDA-approved for acute mania/mixed episodes 2, 1
  • Paliperidone: FDA-approved for acute mania/mixed episodes 1

Mood Stabilizers

  • Lithium: FDA-approved for acute mania and maintenance; high certainty evidence across outcomes 1, 2
  • Divalproex/Valproate: FDA-approved for acute mania 1, 2
  • Carbamazepine: FDA-approved for acute mania 1, 2

Bipolar Depression

Monotherapy Options

  • Quetiapine: FDA-approved as monotherapy for bipolar depression (both immediate-release and extended-release formulations) 3, 4, 5
  • Lurasidone: FDA-approved as monotherapy for bipolar depression 3, 4, 5

Combination Therapy

  • Olanzapine-Fluoxetine Combination (OFC): FDA-approved specifically for bipolar depression 3, 4, 5, 2
  • Lurasidone: Also FDA-approved as adjunct to lithium or valproate for bipolar depression 3, 5

Maintenance Treatment

Only two medications have FDA approval specifically for maintenance therapy based on randomized controlled trials 2:

  • Olanzapine: FDA-approved for maintenance monotherapy
  • Aripiprazole: FDA-approved for maintenance monotherapy

Lamotrigine: While not FDA-approved for acute treatment, it has compelling evidence for maintenance therapy, particularly as adjunct to lithium and for prevention of depressive episodes 1, 5

Pediatric Indications (Children and Adolescents)

For Mania

  • Aripiprazole: High certainty evidence 1
  • Asenapine: High certainty evidence 1
  • Olanzapine: High certainty evidence 1
  • Quetiapine: High certainty evidence 1
  • Risperidone: High certainty evidence 1

For Bipolar Depression

  • Olanzapine-Fluoxetine Combination: Moderate certainty evidence 1
  • Lurasidone: Moderate certainty evidence 1

Key Clinical Considerations

Efficacy profiles: The NNT (number needed to treat) for response ranges from 4-7 and for remission 5-7 across the three FDA-approved bipolar depression treatments, indicating similar efficacy 4.

Tolerability differences are critical for selection 4:

  • OFC: NNH of 6 for ≥7% weight gain
  • Quetiapine: NNH of 16 for ≥7% weight gain; NNH of 3 for somnolence
  • Lurasidone monotherapy: NNH of 58 for ≥7% weight gain (most metabolically favorable)

Common pitfall: None of the classic antidepressants (SSRIs, SNRIs) have FDA approval as monotherapy for bipolar depression—using them alone represents incorrect treatment 4.

Related Questions

Can you provide a table of all FDA‑approved medications for bipolar disorder, including their indications, dosing specifications, and monitoring requirements?
What are the safest medication options and dosing recommendations for treating bipolar disorder during pregnancy?
What is the recommended first-line medication for bipolar disorder?
What are the diagnostic criteria for bipolar disorder?
Which pharmacologic agents are first‑line for bipolar depression, what alternatives should be used if lurasidone (Latuda) has already been tried, how should acute mania be managed, which second‑generation antipsychotics are preferred for a patient with a history of akathisia and how can akathisia be treated beyond propranolol and mirtazapine, how is drug‑induced parkinsonism recognized and managed, what steps are taken for treatment‑resistant schizophrenia after adequate trials of risperidone and olanzapine, and when should naltrexone versus acamprosate be chosen for alcohol use disorder based on medical history and contraindications?
What are the signs and symptoms of bone cancer in the ankle?
Can you provide a table of all FDA‑approved medications for bipolar disorder, including their indications, dosing specifications, and monitoring requirements?
How long can methamphetamine be detected on a urine drug screen?
In a patient who was intubated on the medical‑surgical floor and likely aspirated, currently on assist‑control ventilation with tidal volume 500 mL, respiratory rate 14, PEEP 10 cm H₂O, FiO₂ 100%, with chest X‑ray confirming endotracheal tube placement but oxygen saturation remaining at 49 % despite troubleshooting, what is the next step in management?
Do infants in the United States receive a combined six‑in‑one vaccine covering diphtheria‑tetanus‑pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib), hepatitis B (HepB), pneumococcal conjugate (PCV13), and rotavirus?
What is the appropriate management for a patient who continuously tests positive for methamphetamine while being prescribed Vyvanse (lisdexamfetamine) and Suboxone (buprenorphine/naloxone)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.